Luke Maese

Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Patrick A. Brown, Hiroto Inaba, Colleen Annesley et al. · Journal of the National Comprehensive Cancer Network · 2020 · 204 citations · Full text

Hematological Malignancy, Translational Medicine, Oncology +15

Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG)

Ami V. Desai, Giles Robinson, Karen Gauvain et al. · Neuro-Oncology · 2022 · 121 citations · Full text

Inherited TP53 Variants and Risk of Prostate Cancer

Kara N. Maxwell, Heather H. Cheng, Jacquelyn Powers et al. · European Urology · 2021 · 86 citations · Full text

Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors.

Giles Robinson, Amar Gajjar, Karen Gauvain et al. · Journal of Clinical Oncology · 2019 · 60 citations

Pediatric Brain Tumors, Refractory Cns, Pathology +18

Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer

Alanna J. Church, Laura Corson, Pei‐Chi Kao et al. · Nature Medicine · 2022 · 59 citations · Full text

Pediatric Solid Cancer, Medicine, Pathology +9